Skip to main content
. 2020 May 6;14:112. doi: 10.3389/fncel.2020.00112

TABLE 1.

Evidence supporting the neuroprotective properties of diabetes drugs use in the context of treatments for hypoxia-ischemia encephalopathy.

Diabetes drug Model Species Treatment Effects References
Biguanide OGD bEND.3 cells Metformin Inhibition of inflammatory signaling pathways Liu et al., 2014
Biguanide OGD Rat cortical neurons Metformin Pre-treatment of neurons alleviated OGD/R-induced injury Meng et al., 2016
Biguanide OGD Primary rat fetal-derived astrocytes Metformin Improve cell viability via reduction of apoptosis mechanisms Gabryel and Liber, 2018
Biguanide OGD PC-12 cells Metformin Reduce cell death under OGD/R condition and attenuation of ROS generation Mohammad Alizadeh et al., 2018
Biguanide OGD Primary cortical and hippocampal neurons Metformin Moderate improvement of cell viability Mielke et al., 2006
TZD OGD Rat hippocampal slices NP00111 Rosiglitazone Protection against OGD by a mechanism related to phosphorylation of ERK1/2 via activation of PPARγ Rosa et al., 2008
TZD OGD Primary cultured astrocytes Pioglitazone Protective effects with inhibition of pyroptosis mechanism induced by the OGD Xia et al., 2018
DPP4 OGD HBMVECs Alogliptin Protection against OGD and increasing of permeability in human brain vascular cells Hao et al., 2019
Incretin GLP1-R agonist OGD Rat cortical neurons Exendin-4 Protects neurons through PKA pathway Wang M.-D. et al., 2012
Incretin GLP1-R agonist OGD Rat cortical neurons Liraglutide Neuroprotective action with reduction of apoptosis and ROS via activation of the PI3K/AKT and MAPK pathways Zhu et al., 2016
Incretin GLP1-R agonist OGD Mouse cortical neurons DMB Neuroprotection with anti-apoptotic effects, mediated by activation of the GLP-1R through the cAMP-PKA-CREB signaling pathway Zhang et al., 2016
Sulfonylurea HI P10 Rat Glibenclamide No effects on severe HI model Improvement neurological functions in moderate HI model Zhou et al., 2009
TZD HI 8W Ob/Ob mouse Darglitazone Reduction of the infarct size and neuroinflammation response Kumari et al., 2010
Biguanide HI P8 Mouse Metformin Activation of endogenous NPCs, promoting their migration and differentiation in the injured brain Restoration of sensory-motor function Dadwal et al., 2015
Biguanide HI P3 Rat Metformin Attenuation of cognitive impairments Induction of OPCs proliferation reducing myelination damage Qi et al., 2017
Biguanide HI P7 Rat Metformin Attenuation brain infarct and oedema Inhibition of neuronal apoptosis, and neuroinflammation + amelioration of the blood brain barrier breakdown Fang et al., 2017
Biguanide HI P8 Mouse Metformin Sex-dependent effects on proliferation but increases neurogenesis in both sexes; rescues cognitive deficits in adult females Ruddy et al., 2019
Incretin GLP1-R agonist HI P7/P10 Mouse Exendin-4** Neuroprotective effect alone or in combination with therapeutic hypothermia Rocha-Ferreira et al., 2018
Incretin GLP1-R agonist HI P7 Rat Liraglutide Inhibited apoptosis and promoted neuronal survival; PI3K/Akt pathway involved Zeng et al., 2020

In vitro model with OGD on different cell types and in vivo models with HI at different stage of age. **Only study using combination with hypothermia.